 |
Leo Santamarina, M.D. |
 |
| Education
East Brunswick Public High School Class of 1980
East Brunswick, NJ
Valedictorian, age 15
Brown University 1980 - 1984
Providence, RI
Magna Cum Laude with Honors
Degree- B.S., Neuroscience
University of Medicine and Dentistry of New Jersey 1984 - 1988
Robert Wood Johnson Medical School
Piscataway, NJ
Honors in pediatric ophthalmology
Honors in ophthalmology research
Degree – M.D.
The Bryn Mawr Hospital 1988 - 1991
Bryn Mawr, PA
Residency in Internal Medicine
Chief Resident
State University of New York Health Science Center 1991 - 1994
Kings County Hospital Center
Brooklyn, NY
Residency in Ophthalmology
Tulane University of Louisiana 1994 - 1996
New Orleans, LA
Fellowship- Vitreoretinal Surgery
Employment History
Retina Vitreous Associates 1996-1999
8000 Ravine’s Edge Court, Suite 100
Columbus, OH 43235
Ophthalmic Partners of Pennsylvania 1999 - 2005
201 Sabine Avenue
Narberth, PA 19072
Staff Appointments
Christiana Care Health Services 1999 - Present
Wilmington, DE
Provisional Staff
Hahnemann University Hospital 1999 - Present
Philadelphia, PA
Active Privileges
Drexel University College of Medicine 1999 - Present
Philadelphia, PA
Clinical Assistant Professor of Ophthalmology
Vice Chairman Department of Ophthalmology
St. Francis Hospital 1999 - Present
Wilmington, DE
Active Staff
Board Certified
American Board of Ophthalmology October 15, 1995
Society Memberships
American Society of Retina Specialists 1999 - Present
(Formerly The Vitreous Society)
Delaware Academy of Ophthalmology 1999 - Present
President (DAO) 2003- 2005
Medical Society of Delaware 1999- Present
New Castle County Medical Society 1999- Present
Additional Skills
Fluent in Spanish and conversant in Portuguese
Play several instruments including piano, drums and the Spanish bagpipes. |
Research And Publications
1. Lent CM, Santamarina L. 6-Hydroxydopamine Produces Lesions of Serotonin-containing Retzius Cells in the Leech Nervous System. Brain Research, 323:335-341, 1984.
2. DellaVecchia MA, Santamarina L. Ocular Cieatricial Pemphigoid. Presented paper at Pennsylvania Academy of Ophthalmology and Otolaryngology in Hershey, PA, June 1990.
3. Smith EF, Santamarina L, Wolintz AH. Herpes Zoster Ophthalmicus as a Cause of Horner Syndrome. J Clin Neuro-ophthalmol, 13:250-253, 1993.
4. Santamarina L, Samad A, Maxwell DP, Diamond JG. AMPPE Associated with Severe Uveitis and Persistent Visual Loss. Report and presentation at ARVO in Ft. Lauderdale, FL, May 1995.
5. Samad A, Santamarina L, Maxwell DP, Diamond JG. Recurrent Bilateral Multiple Evanescent White Dot Syndrome with Subfoveal Neovascularization. Report and presentation at ARVO in Ft. Lauderdale, FL., May 1995.
6. Lee AM, Santamarina L, Diamond JG, Maxwell DP, Wong WJ. Does Viscoelastic Mask the Signs of Endophthalmitis after Cataract Surgery. Presentation at ARVO in Ft. Lauderdale, Fl., May 1997.
7. Reviewer for peer review journal, Ophthalmology.
Presentations
John T. Convillion, M.D., Leo Santamarina, M.D., James G. Diamond, M.D. Progressive Systemic Sclerosis Presenting with Decreased Vision. Presentation at 90th Annual Scientific Assembly of the Southern Medical Association in Baltimore, Maryland, November 20-24, 1996.
“Photodynamic Therapy for Macular Degeneration” 53rd Annual Conference, Wills Eye Hospital, Philadelphia, PA, March 29, 2001.
Leo Santamarina, M.D. Severe Uveitis/ Retinitis Resulting in Precipitous Complete Loss of Light Perception. Presentation at Retina Club Meeting, Wills Eye Hospital, Philadelphia, PA., October 5,6, 2001.
“Idiopathic Polypoidal Chorioretinopathy,” presented at the Annual Fluorescein Conference, Wills Eye Hospital, Philadelphia, PA., September 13, 2002.
“Overview of the Ocular Complications of Diabetes,” presented at Delaware Diabetes Wellness Expo, The Delaware Diabetes Coalition, Sheraton Dover Hotel, Dover, Delaware. November 19, 2002.
“Radial Optic Neurotomy in the Management of Central Vein Occlusion,” presented at the Annual Fluorescein Conference, Wills Eye Hospital, Philadelphia, PA, September 14, 2002.
“Radial Optic Neurotomy in the Management of Central Vein Occlusion,” presented at the Ophthalmic Club Meeting, Philadelphia, PA, February 3, 2003.
IDE
Investigator (#5307): STOP-ROP Multicenter Study of retinopathy of Prematurity.
Sub-Investigator: An Open-Label, Multicenter, Safety Study of the Treatment of Predominantly Classic Subfoveal Choroidal Neovascularization (CNV) Secondary to Age related Macular Degeneration (AMD) using Photodynamic Therapy with Verteporfin for Injection. Protocol BPD OCR 005. Main Line Surgery Center, 1999.
Sub-Investigator: A Phase 2 Open-Label Randomized Dose-Ranging Study of the Safety and Efficacy of Intravenous Anidulafungin (VER 002) in the Treatment of Patients with Invasive Candidiasis VER002, June 5, 2001 to Feb. 2003.
Sub-Principal Investigator: A Phase III, Double-Blind, Randomized, Multi-Center Study of the Safety and Efficacy of Anidulafungin VS. Fluconazole in the Treatment of Patients with Candidemia and Other Forms of Invasive Candidiasis and prevention of Complications, April 21, 2003.
